Pfizer temporarily reducing the supply of its Covid-19 vaccine in Europe

1 min read

- Commercial -

Well being officers of Norway mentioned on Friday – That US Pharmaceutical Firm Pfizer goes to scale back the availability of its Covid-19 Vaccine in Europe. As a result of the corporate needs to extend the availability capability of its Corona Vaccine.

The Director of the an infection management division mentioned – “We have received this message today by Company side”. They mentioned – “We said that we need 43.875 doses of their vaccine in the upcoming three weeks, but now it seems we will get only 36,075 doses of Pfizer vaccine”

Additionally Learn: The French well being ministry will pace up the Covid-19 vaccination marketing campaign

It mentioned, “All European countries will be affected by this temporary reduction.” Norway will not be a part of the European Union. Nevertheless, neither Pfizer nor its German associate BioNotech has but confirmed the availability shortfall.

- Commercial -

Rate This Article

Click to rate

Socially Keeda

Content Director

Socially Keeda is the newsroom’s news assistant that brings you clarity in a world of fake news. We speak with journalists, readers and community voices to find practical insights about culture, finances, tech and life. Each post is designed to make it possible for you to learn something useful without hype from busy people making sure they still have time for other things in life and at work.

- Advertisement - Continue Reading Below -